Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms by Site 1Neoplasms 1Genital Neoplasms, Female 1Fallopian Tube Neoplasms 1Fallopian Tube Diseases 1Endometrial Neoplasms 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Oxaliplatin 5Mitomycin 4Hyperthermic Intraperitoneal Chemotherapy 4Fluorouracil 4Cisplatin 4Doxorubicin 3Standard of Care 2Paclitaxel 2Leucovorin 2Docetaxel 2Blood Specimen Collection 2Bevacizumab 2sodium thiosulfate 1relacorilant 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1X-Rays 1Topotecan 1Specimen Handling 1Practice Guidelines as Topic 1Platinum 1Pancreatectomy 1Pafolacianine 1Observation 1Mitozytrex 1Magnetic Resonance Spectroscopy 1Letrozole 1Laparoscopy 1LY-2157299 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Peritoneal Neoplasms × relacorilant × Clear all
NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Corcept Therapeutics

Phase 2 Recruiting
270 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡